Cullinan Therapeutics Cash Flow Statement (2020-2026) | CGEM

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.44M-18.26M-34.21M-12.89M174.06M-24.89M-27.05M-58.14M-32.21M-39.18M-53.78M-40.86M-45.00M-40.71M-178.47M-48.71M-70.05M-51.74M-50.65M-52.35M
Share-based Compensation (Quarter)
4.17M4.56M12.14M6.57M8.61M5.27M7.51M7.26M7.92M7.74M7.52M8.23M10.53M9.43M9.63M9.37M9.89M9.47M7.31M7.62M
Deferred Taxes (Quarter)
-19.57M
Asset Writedowns and Impairment (Quarter)
0.40M
Cash from Operations (Quarter)
-16.20M-10.55M-15.17M-21.91M-25.42M-54.35M-24.98M-51.00M-31.01M-34.14M-18.13M-38.25M-36.29M-34.14M-36.63M-43.16M-57.61M-36.88M-38.11M-46.05M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.06M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M
Change in Working Capital
Change in Account Payables (Quarter)
-2.37M0.52M1.15M3.14M-3.21M-1.58M1.15M-0.63M0.46M-1.54M1.54M1.21M-2.15M0.56M-0.43M1.72M-0.94M-0.74M-0.88M1.67M
Change in Accured Expenses (Quarter)
-1.60M1.60M2.77M1.03M4.69M1.23M1.58M2.64M-2.82M5.17M5.06M-7.53M3.60M-0.06M6.89M-5.25M1.61M5.49M6.18M-4.31M
Change in Taxes (Quarter)
46.50M-35.10M-7.12M-0.07M-4.21M
Investing Activities
Capital Expenditures (Quarter)
0.25M0.88M0.16M0.05M0.01M
Change in Acquisitions & Divestments (Quarter)
58.90M59.71M61.40M91.73M67.20M61.40M132.60M104.48M93.61M93.82M117.48M144.32M139.82M116.67M184.00M162.65M131.93M80.00M42.00M52.55M
Cash from Investing Activities (Quarter)
-154.59M-25.59M-15.86M34.71M300.85M-57.98M-28.61M15.18M12.11M-42.96M51.47M12.96M-185.11M19.88M15.96M36.80M53.40M67.39M22.39M32.41M
Financing Activities
Other financing activities (Quarter)
-266.35M1.15M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.80M1.40M
Change in Capital Stock
Shares Issued (Quarter)
4.62M1.75M9.26M9.33M10.54M11.63M9.45M
Net Equity Issued and Repurchased (Quarter)
0.58M2.70M0.80M-0.80M2.38M1.82M262.65M
Dividend Payments
Dividends Paid - Common (Quarter)
3.79M0.66M
Misc.
Cash from Financing Activities (Quarter)
0.92M0.58M2.70M3.54M2.01M1.43M-32.91M1.79M38.60M0.11M0.25M1.08M262.20M1.32M1.58M0.37M0.71M0.38M
Change in Cash (Quarter)
-169.87M-35.56M-28.33M16.34M277.44M-110.91M-86.50M-34.02M19.71M-76.99M33.59M-24.21M40.79M-12.94M-19.08M-6.35M-3.83M30.52M-15.00M-13.25M
Free Cash Flow (Quarter)
-16.20M-10.55M-15.17M-21.91M-25.42M-54.60M-25.86M-51.16M-31.05M-34.14M-18.13M-38.25M-36.29M-34.14M-36.63M-43.16M-57.61M-36.88M-38.12M-46.05M
Net Cash Flow (Quarter)
-169.87M-35.56M-28.33M16.34M277.44M-110.91M-86.50M-34.02M19.71M-76.99M33.59M-24.21M40.79M-12.94M-19.08M-6.35M-3.83M30.52M-15.00M-13.25M